جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib teva 20mg potahovaná tableta
teva b.v., haarlem array - 17698 monohydrÁt dasatinibu - potahovaná tableta - 20mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib teva 70mg potahovaná tableta
teva b.v., haarlem array - 17698 monohydrÁt dasatinibu - potahovaná tableta - 70mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
miglustat accord 100mg tvrdá tobolka
accord healthcare polska sp. z o.o., varšava array - 16508 miglustat - tvrdá tobolka - 100mg - miglustat
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib viatris 20mg potahovaná tableta
viatris limited, dublin array - 17512 dasatinib - potahovaná tableta - 20mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib viatris 50mg potahovaná tableta
viatris limited, dublin array - 17512 dasatinib - potahovaná tableta - 50mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib viatris 70mg potahovaná tableta
viatris limited, dublin array - 17512 dasatinib - potahovaná tableta - 70mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib zentiva 20mg potahovaná tableta
zentiva, k.s., praha array - 17512 dasatinib - potahovaná tableta - 20mg - dasatinib
جمهورية التشيك -
التشيكية -
SUKL (Státní ústav pro kontrolu léčiv)
dasatinib zentiva 70mg potahovaná tableta
zentiva, k.s., praha array - 17512 dasatinib - potahovaná tableta - 70mg - dasatinib
الاتحاد الأوروبي -
التشيكية -
EMA (European Medicines Agency)
opfolda
amicus therapeutics europe limited - miglustat - glykogen storage type ii - ostatní produkty trávicího traktu a metabolismu - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).
الاتحاد الأوروبي -
التشيكية -
EMA (European Medicines Agency)
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastická činidla - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.